Medtech
Further German cooperation with the Paracelsus Clinic in Zwickau and first NanoTherm treatment center outside of Germany opened at the Independent Public Clinical Hospital No. 4 (SPKS4) in Lublin, Poland
Hebrew SeniorLife, a Harvard Medical School Affiliate, is Fourth Study Site
New solution supports injection of different viscosities and volumes without the need for system customization
Findings further validate Cell Pouch and therapeutic cell performance in
Magnetic Insight, Inc., the leader in Magnetic Particle Imaging solutions, announced that David Panzarella has been appointed as the company’s Chief Commercial Officer.
The jury found the company failed to warn patients of a side effect causing young men who used the drug to grow breasts (gynecomastia).
Successful review of HEMOBLAST Bellows’ performance and safety profile as well as Biom’up’s Quality Management System by the Australian Therapeutic Goods Administration (TGA)
Results demonstrates that use of KneeKG in patients with osteoarthritis reduces pain, improves patient quality of life, and may reduce need for unnecessary surgery.
Magnetic Insight, Inc., the leader in Magnetic Particle Imaging solutions, announced that it was awarded a Small Business Innovation Research grant from the National Cancer Institute of the National Institutes of Health under Award Number R43CA233155.
Estimated total sales of HEMOBLAST™ Bellows for the first nine months of 2019 are expected to show strong growth at €2.5 million (compared to €1.5 million for the first half of 2019 and €0.6 million for the full year 2018) and are expected to be on track to achieve the 2019 revenue guidance range of €4.0-€4.5 million
PRESS RELEASES